These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose]. Bakker SC; Zanin DE; Zweers EJ Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370 [TBL] [Abstract][Full Text] [Related]
27. [Radioiodine 131I therapy of hyperthyroidism on an outpatient basis - safe, effective and economic option]. Jiskra J; Kubinyi J; Telička Z Vnitr Lek; 2012 Feb; 58(2):94-8. PubMed ID: 22463087 [TBL] [Abstract][Full Text] [Related]
28. [Results of fractionated radioiodine therapy in 696 patients with hyperthyroidism and 690 patients with non-toxic goiter]. Klein B; Klein E; Horster FA Nuklearmedizin; 1989 Aug; 28(4):129-36. PubMed ID: 2780331 [TBL] [Abstract][Full Text] [Related]
29. Variability of the administered radioiodine doses for the treatment of hyperthyroidism in Belgium. Tondeur M; Glinoer D; Sand A; Verelst J; Ham H Clin Endocrinol (Oxf); 2006 Aug; 65(2):206-9. PubMed ID: 16886961 [TBL] [Abstract][Full Text] [Related]
30. Results of radioiodine (131/125I) therapy of hyperthyroidism. Glanzmann C; Horst W; Magdeburg W Radiol Clin (Basel); 1975; 44(5):484-90. PubMed ID: 1208842 [TBL] [Abstract][Full Text] [Related]
31. Radioiodine therapy of benign thyroid disorders: what are the effective thyroidal half-life and uptake of 131I? Kobe C; Eschner W; Wild M; Rahlff I; Sudbrock F; Schmidt M; Dietlein M; Schicha H Nucl Med Commun; 2010 Mar; 31(3):201-5. PubMed ID: 19907353 [TBL] [Abstract][Full Text] [Related]
33. Successful treatment of solitary toxic thyroid nodules with relatively low-dose iodine-131, with low prevalence of hypothyroidism. Ross DS; Ridgway EC; Daniels GH Ann Intern Med; 1984 Oct; 101(4):488-90. PubMed ID: 6476634 [TBL] [Abstract][Full Text] [Related]
34. [Results of radioiodine treatment of patients with immunogenic and non-immunogenic hyperthyroidism using different focal doses]. Moser E; Pickardt CR; Mann K; Engelhardt D; Kirsch CM; Knesewitsch P; Tatsch K; Kreisig T; Kurz C; Saller B Nuklearmedizin; 1988 Jun; 27(3):98-104. PubMed ID: 3405782 [TBL] [Abstract][Full Text] [Related]
35. One-year follow-up of Graves' disease treatment by four different protocols of radioiodine administration. Calegaro JU; De Freitas Gomes E; Bae SH; Ulyssea R; Casulari LA Panminerva Med; 2000 Dec; 42(4):241-5. PubMed ID: 11294085 [TBL] [Abstract][Full Text] [Related]
36. [Results of radioiodine therapy in different forms of hyperthyroidism in relation to the planned dosage]. Moser E Aktuelle Radiol; 1992 Jul; 2(4):179-87. PubMed ID: 1504115 [TBL] [Abstract][Full Text] [Related]
37. Comparison of the long-term efficacy of low dose 131I versus antithyroid drugs in the treatment of hyperthyroidism. Chen DY; Jing J; Schneider PF; Chen TH Nucl Med Commun; 2009 Feb; 30(2):160-8. PubMed ID: 19194213 [TBL] [Abstract][Full Text] [Related]
38. [Thyroid diseases in sub-Saharan Africa]. Sidibé el H Sante; 2007; 17(1):33-9. PubMed ID: 17897900 [TBL] [Abstract][Full Text] [Related]
39. [Radioiodine versus surgery in the treatment of Graves' hyperthyroidism]. Jukić T; Stanicić J; Petric V; Kusić Z Lijec Vjesn; 2010; 132(11-12):355-60. PubMed ID: 21294325 [TBL] [Abstract][Full Text] [Related]
40. [Behavior of serum triiodothyronine in subjects treated with I-131 for hyperthyroidism]. Bagnasco M; Biassoni P; Clemente GF; Vibracci G; Ferrini O Arch Maragliano Patol Clin; 1975; 31(1):77-87. PubMed ID: 1244069 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]